Trials / Completed
CompletedNCT02447393
Phase 1 Study of Levocetirizine
A Single Blind, Randomized, Single Oral Dose Study to Compare the Oral Disposition of Levocetirizine When Given Alone (5mg) or as the Racemate (Cetirizine 10mg), and to Investigate the Safety and Tolerability and the Pharmacokinetics of Levocetirizine and Cetirizine, Following a Single Dose in Healthy Japanese Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- Male
- Age
- 20 Years – 64 Years
- Healthy volunteers
- Accepted
Summary
This is a single center, single blind, single dose, randomized, partial cross-over study to confirm bioequivalence between levocetirizine and cetirizine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | levocetirizine | levocetirizine |
| DRUG | cetirizine | cetiridine |
| DRUG | placebo | placebo |
Timeline
- Start date
- 2008-03-18
- Primary completion
- 2008-04-30
- Completion
- 2008-04-30
- First posted
- 2015-05-18
- Last updated
- 2017-08-03
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT02447393. Inclusion in this directory is not an endorsement.